Handelsbanken Fonder
KRYS icon

Handelsbanken Fonder’s Krystal Biotech KRYS Stock Holding History

Handelsbanken Fonder’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6M Sell
90,407
-993
-1% -$297K 0.1% 179
2026
Q1 		$23.6M Sell
91,400
-14,400
-14% -$3.83M 0.08% 209
2025
Q4 		$26.1M Buy
105,800
+39,000
+58% +$8.21M 0.08% 217
2025
Q3 		$11.8M Hold
66,800
– – 0.04% 347
2025
Q2 		$9.18M Sell
66,800
-7,500
-10% -$1.1M 0.03% 359
2025
Q1 		$13.4M Sell
74,300
-11,000
-13% -$1.85M 0.06% 294
2024
Q4 		$13.4M Sell
85,300
-9,400
-10% -$1.67M 0.05% 311
2024
Q3 		$17.2M Sell
94,700
-11,800
-11% -$2.28M 0.07% 259
2024
Q2 		$19.6M Buy
106,500
+1,300
+1% +$218K 0.09% 211
2024
Q1 		$18.7M Sell
105,200
-18,000
-15% -$2.5M 0.08% 233
2023
Q4 		$15.3M Buy
123,200
+10,400
+9% +$1.15M 0.07% 254
2023
Q3 		$13.1M Buy
112,800
+5,600
+5% +$683K 0.07% 270
2023
Q2 		$12.6M Buy
107,200
+2,000
+2% +$204K 0.07% 295
2023
Q1 		$8.42M Hold
105,200
– – 0.05% 350
2022
Q4 		$8.33M Buy
105,200
+300
+0.3% +$22.3K 0.05% 347
2022
Q3 		$7.31M Sell
104,900
-8,000
-7% -$578K 0.05% 339
2022
Q2 		$7.41M Buy
112,900
+2,900
+3% +$180K 0.05% 349
2022
Q1 		$7.32M Buy
110,000
+20,000
+22% +$1.25M 0.04% 392
2021
Q4 		$6.3M Hold
90,000
– – 0.03% 445
2021
Q3 		$4.7M Hold
90,000
– – 0.02% 483
2021
Q2 		$6.12M Hold
90,000
– – 0.03% 450
2021
Q1 		$6.93M Hold
90,000
– – 0.04% 369
2020
Q4 		$5.4M Hold
90,000
– – 0.03% 399
2020
Q3 		$3.87M Hold
90,000
– – 0.03% 410
2020
Q2 		$3.73M Buy
+90,000
New +$4.33M 0.03% 400

Other funds holding KRYS

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PIP
Palisades Investment Partners Santa Monica, California $352M AUM 76.79% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Handelsbanken Fonder's KRYS Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Krystal Biotech (KRYS) stake by 1.1% in Q2 2026, selling an estimated $297K and leaving 90,407 shares worth $33.6M. The position accounts for 0.1% of the portfolio, ranked #179.

Handelsbanken Fonder first reported a position in KRYS in Q2 2020 and has held it in 25 quarters since. 153 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Handelsbanken Fonder held 90,407 shares of Krystal Biotech worth $33.6M as of Q2 2026.
  • Handelsbanken Fonder sold 993 Krystal Biotech shares in Q2 2026, an estimated $297K.
  • Krystal Biotech made up 0.1% of Handelsbanken Fonder's portfolio in Q2 2026, its #179 holding.
  • Handelsbanken Fonder first reported a position in Krystal Biotech in Q2 2020 and has held it in 25 quarters since.
  • 153 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.